Breaking News

ABILIFY – The evidence base for the prescribing of aripiprazole in maintenance treatment of bipolar disorder is limited to a single trial, sponsored by the manufacturer of aripiprazole

Public release date: 3-May-2011 Limitations of evidence base for prescribing aripiprazole in maintenance therapy of bipolar disorder - The evidence base for the prescribing of...